Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Cardiovascular Drugs and Therapy|February 7, 2008
Medium-chain fatty acids as metabolic therapy in cardiac diseaseFrançois Labarthe, Roselle Gélinas, Christine Des Rosiers
Journal of Allergy|July 13, 2011
Lability of IgE Levels Early in LifeKoffi N'guessan, David Ternant, François Labarthe, et al.
Orphanet Journal of Rare Diseases|February 14, 2024
Blood cytopenias as manifestations of inherited metabolic diseases: a narrative reviewYannick Moutapam-Ngamby-Adriaansen, François Maillot, François Labarthe, et al.
Cardiovascular Research|March 15, 2011
Cardiac anaplerosis in health and disease: food for thoughtChristine Des Rosiers, François Labarthe, Steven G Lloyd, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 20, 2004
Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acidFrançois Labarthe, Maya Khairallah, Bertrand Bouchard, et al.
Soins. Pediatrie, Puericulture|June 28, 2011
[The nutritional care of a child suffering from neuroblastoma]Mathilde Boisson, Géraldine Senon, Anne Jourdain, et al.
Molecular Genetics and Metabolism|June 10, 2026
Recurrent hemophagocytic lymphohistiocytosis in COG deficiency: a case series and systematic review of inflammatory manifestationsAntoine de Laitre, Magalie Barth, François Labarthe, et al.
ESC Heart Failure|August 24, 2023
Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: towards therapeutic options?Jean Issa, Pierre Lodewyckx, Hélène Blasco, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 13, 2003
Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbonsMaya Khairallah, François Labarthe, Bertrand Bouchard, et al.
Pageof 6